Jayagopal Ashwath 4

What Happened

• Jayagopal Ashwath, Chief Scientific & Development Officer of Opus Genetics (IRD), had 3,719 shares disposed on March 16, 2026. The shares were sold for a weighted average price of $5.12 per share, generating proceeds of approximately $19,046.
• This sale was an automatic transaction to satisfy tax withholding obligations related to the vesting/settlement of restricted stock units (RSUs), not a discretionary open-market trade by the insider.

Key Details

• Transaction date: March 16, 2026; Form 4 filed March 18, 2026 (timely filed).
• Price: weighted average $5.12; individual sale prices ranged from $5.11 to $5.1301. The shares were sold in multiple transactions.
• Shares sold: 3,719; proceeds ≈ $19,046.
• Shares owned after transaction: not specified in the provided excerpt.
• Notable footnotes: F1 — sale was automatic to satisfy tax withholding from an RSU vesting/settlement (not discretionary). F2 — weighted average price reported; issuer/SEC staff can request the per-trade price breakdown.

Context

• This was a tax-withholding sale tied to RSU settlement (transaction code typically F), which is a routine administrative event and does not necessarily signal the insider’s view of the company.
• No option exercise, gift, or 10% owner change is involved; it reflects fulfillment of tax obligations on vested equity.